MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Suicidality in Parkinson’s Disease: A Case Control Study

    M. Akbostanci, E. Bayram, D. Sayar, T. Ayidaga (Ankara, Turkey)

    Objective: To investigate suicidality in Parkinson's disease (PD) by a case control study Background: Depression, a risk factor for suicidality, is rather common in PD patients. Nevertheless,…
  • 2017 International Congress

    Sports or no sports – is that the question in PD?

    M. Strothjohann, P. Kostopoulos, F. Weber (Bad Camberg, Germany)

    Objective: A multitude of risk factors or protective factors in developing Parkinson’s Disease (PD) are under discussion, as caffeine consumption or smoking ..  Background: Frequent physical activity…
  • 2017 International Congress

    Association of vitamin D deficiency in Parkinson disease

    A. MUJTABA, N. ALSOMALI, A. ALSHAMRANI, S. MARAR, T. Alayan, J. BAJWA (RIYADH, Saudi Arabia)

    Objective: To identify the association between vitamin D deficiency and  PD in an Arab cohort.  Background: A growing body of evidence suggests that vitamin D…
  • 2017 International Congress

    The Pull Test in healthy subjects and Parkinson´s disease: quantitative pull-force measure, postugraphic and electromyographic analysis

    J.R. Perez-Sanchez, B. DeLaCasa-Fages, A. Contreras, J.M. Velázquez, A. Muñoz-González, F. Grandas (Madrid, Spain)

    Objective: To study and compare in healthy subjects and patients with Parkinson´s disease (PD) the destabilizing force needed to reach the limit of stability (LoS), the displacements of…
  • 2017 International Congress

    Slow Release Fixed Dose Combination of Low Doses Pramipexole and Rasagiline (P2B001) for the Treatment of Early Parkinson’s Disease (PD).

    C. Olanow, K. Kieburtz, N. Livnah (New York, NY, USA)

    Objective: Evaluation of the efficacy and safety of a slow release low dose combination of pramipexole (PPX) and rasagiline (RAS) (P2B001) in a prospective double-blind…
  • 2017 International Congress

    Comparison of hand functions between people with Parkinson’s disease and healthy subjects

    M. Mak, I. Wong (Hong Kong, Hong Kong)

    Objective: To compare the hand functions between Parkinson’s Disease (PD) and healthy subjects using objective and subjective measures; and to establish the correlations among outcome…
  • 2017 International Congress

    Spinal cord stimulation as therapeutic option in gait disorder in Parkinson disease.

    H. Cécile, D'H. Vincent, B.M. MALEK, p.-k. nathalie, t. Jean-Batiste, Z. MARC, B. Jean-Philippe (PARIS, France)

    Objective: We aim to study the effect of spinal cord stimulation over gait in parkinson disease without pain nor neuropathy. Background: Axial symptoms in the course…
  • 2017 International Congress

    Levodopa/carbidopa Intestinal Gel Can Improve Both Motor and Non-Motor Experiences of Daily Living in Parkinson’s Disease: An Open-Label Study

    N. Kovacs, A. Juhász, Z. Aschermann, P. Ács, J. Janszky, M. Kovács, A. Makkos, M. Harmat, D. Tényi, K. Katádi, S. Komoly, A. Takáts, A. Tóth, H. Nagy, P. Klivényi, G. Dibó, L. Dézsi, D. Zádori, Á. Annus, L. Vécsei, L. Varannai (Pécs, Hungary)

    Objective: : Our aim was to determine if the MDS-UPDRS and UDysRS could detect improvement in the experiences of daily living following 1-year LCIG treatment.…
  • 2017 International Congress

    Relationship between non-motor symptoms and dopamine transporter activity in Parkinson’ s disease

    M. Iijima, H. Yoshizawa, Y. Uchiyama, K. Abe, K. Kitagawa (Tokyo, Japan)

    Objective: We investigated whether dopamine transporter single-photon emission computed tomography (DAT-SPECT) binding correlates to non-motor symptoms in patients with Parkinson’s disease (PD). Background: DAT-SPECT binding…
  • 2017 International Congress

    Grey matter abnormalities associated with early cognitive decline in Parkinson’s disease

    A. Moonen, R. Lopes, A. Leentjens, A. Duits, K. Dujardin (Maastricht, Netherlands)

    Objective: To identify patterns of grey matter (GM) abnormalities in patients with Parkinson's disease (PD) with different cognitive profiles.  Background: Cognitive symptoms occur already in…
  • « Previous Page
  • 1
  • …
  • 308
  • 309
  • 310
  • 311
  • 312
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley